APA Alıntı

Ofotokun, I., Na, L. H., Landovitz, R. J., Ribaudo, H. J., McComsey, G. A., Godfrey, C., . . . Currier, J. S. (2015). Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257. Clin Infect Dis.

Chicago Stili Alıntı

Ofotokun, Ighovwerha, et al. "Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257." Clin Infect Dis 2015.

MLA Alıntı

Ofotokun, Ighovwerha, et al. "Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257." Clin Infect Dis 2015.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..